Apotex Health Corp experienced a notable uptick in its stock price, reflecting positive market sentiment.
Apotex Health Corp (APTX.TO) saw a significant increase in its stock price, rising by 6.60% yesterday to close at CA$35.55. This surge highlights investor confidence in the company's recent performance and strategic initiatives.
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.33B
52W high
$40.11
52W low
$26.01
1W change
-4.73%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 31.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+31.5% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$31.45
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
44.1%
Annualized
90-Day Vol
48.8%
Annualized
Trend (90d)
-32.1%
Annualized drift
90d Mean
C$28.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$30.27 | C$26.00 – C$35.24 |
| 60 trading days | C$29.13 | C$23.50 – C$36.12 |
| 90 trading days | C$28.04 | C$21.55 – C$36.49 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The recent surge in Apotex's stock price indicates a growing optimism among investors, potentially driven by the company's strong revenue growth and strategic moves.
6.60% Surge in Stock Price
Apotex Health Corp's stock price increased by 6.60% yesterday, reflecting a strong market response to its recent financial performance.
Bull case
Investors might feel encouraged by Apotex's announcement of an 11% revenue growth for Q1 2027, along with a successful IPO that improved its financial standing. These developments could suggest a promising future for the company.
Bear case
Despite the positive movement, Apotex's profit margin is still negative, which could raise concerns about its long-term profitability and sustainability, especially in a competitive market.
Recent Financial Performance
Advertisement
Apotex reported an 11% revenue growth in Canada for Q1 2027, with an adjusted EBITDA of $259 million and a 31% margin. This strong performance has likely contributed to the positive sentiment surrounding the stock.
Strategic Initiatives
The company recently completed an upsized IPO, applying $800 million of proceeds to debt repayment. This strategic move has positioned Apotex as a more stable investment-grade-rated issuer, further boosting investor confidence.
Market Reactions
The stock's 6.60% increase yesterday reflects a favorable market reaction to Apotex's recent announcements and financial results. Investors are optimistic about the company's future, but ongoing scrutiny of its profit margins remains essential.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
